Congress must permit donors to accept third-party benefits for saving the life of a stranger, otherwise desperate patients and donors will continue to be reluctant co-conspirators in crime.

While biopharmaceutical companies may be thought of as mission oriented, they are almost certainly the poster children for adaptation. They need to focus on finding the most pressing relevant issues to help their patients.

Israel should be commended for its two-pronged approach to its organ problem: incentives and efforts to combat trafficking.

It is time for a state to challenge the 1984 National Organ Transplant Act and offer funeral benefits or some other reward to the estate of those who will give their organs at death.

Governments must provide in-kind incentives in order to spur organ donations, as altruism cannot be the sole legitimate motive for donating, and to achieve the true end of saving more lives.

What should we make of Arizona's new law for rationing organ transplants?

The organ transplant list is approaching 100,000 patients, but the waitlist doesn't reflect the full scope of the problem.

We must enable more patients in wealthy countries to obtain transplants at home by empowering their governments, under strict regulation, to offer incentives to prospective donors.